1-2 of 2
Senaka Peter, MPH
Close
Sort by
Journal Articles

The Presence of the BCR-ABL T315I Mutation In Chronic Phase Chronic Myelogenous Leukemia Resistant to Tyrosine Kinase Inhibitors Profoundly Compromises Overall Survival and Progression Free Survival. Preliminary Results of a Matched Pair Analysis.

Franck E Nicolini, MD, PhD, Stephane Morisset, Stat., Andreas Hochhaus, Giovanni Martinelli, MD, Dong-Wook Kim, MD, PhD, Inge Dufva, MD, Michael Mauro, MD, Jorge E. Cortes, MD, Charles Chuah, MBChB, FRCPE, MD, Jane Apperley, MBChB, FRCP, FRCPath, Francois Guilhot, Giuseppe Saglio, MD, PhD, Martin C. Mùˆller, Simona Soverini, Selim Corm, MD, PhD, Isabelle Tigaud, MD, Madeleine Etienne, CRA, Catherine Roche-Lestienne, PhD, Sandrine Hayette, PhD, Senaka Peter, MPH, Wei Zhou, MD, PhD, Mauricette Michallet, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3410.
https://doi.org/10.1182/blood.V116.21.3410.3410
Published: 2010
Journal Articles

Impact of Allogeneic Stem Cell Transplantation as Salvage Therapy After T315I Mutation Detection in Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL) Patients.

Franck Emmanuel Nicolini, MD, PhD, Wei Zhou, MD, PhD, Giovanni Martinelli, MD, Michael J. Mauro, MD, Andreas Hochhaus, MD, Jing Su, MS, Jane Apperley, MD, Charles Chuah, MD, Inge Dufva, MD, Dong-Wook Kim, MD, PhD, Francis J. Giles, MB,MD,FRCPI,FRCPath, Senaka Peter, MPH, Jorge Cortes, MD
Journal: Blood
Blood (2009) 114 (22): 645.
https://doi.org/10.1182/blood.V114.22.645.645
Published: 2009